Carbon Nanomaterials and LED Irradiation as Antibacterial Strategies against Gram-Positive Multidrug-Resistant Pathogens

被引:30
|
作者
Elias, Lisa [1 ]
Taengua, Rafael [2 ]
Frigols, Belen [2 ]
Salesa, Beatriz [2 ]
Serrano-Aroca, Angel [2 ]
机构
[1] Univ Ghent, Dept Biochem & Biotechnol, Krijgslaan 281, B-9000 Ghent, Belgium
[2] Univ Catolica Valencia San Vicente Martir, Fac Vet & Ciencias Expt, C Guillem de Castro 94, Valencia 46001, Spain
关键词
carbon nanomaterials; antibacterial activity; graphene oxide; carbon nanofibers; LED; methicillin-resistant Staphylococcus aureus; methicillin-resistant Staphylococcus epidermidis; cytotoxicity; human keratinocyte HaCaT cells; GRAPHENE OXIDE; ANTIMICROBIAL ACTIVITY; SILVER NANOPARTICLES; RAMAN-SPECTRA; LIGHT; NANOTECHNOLOGY; HYDROGELS; MECHANISMS; PEPTIDES; BACTERIA;
D O I
10.3390/ijms20143603
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Due to current antibiotic resistance worldwide, there is an urgent need to find new alternative antibacterial approaches capable of dealing with multidrug-resistant pathogens. Most recent studies have demonstrated the antibacterial activity and non-cytotoxicity of carbon nanomaterials such as graphene oxide (GO) and carbon nanofibers (CNFs). On the other hand, light-emitting diodes (LEDs) have shown great potential in a wide range of biomedical applications. Methods: We investigated a nanotechnological strategy consisting of GO or CNFs combined with light-emitting diod (LED) irradiation as novel nanoweapons against two clinically relevant Gram-positive multidrug-resistant pathogens: methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE). The cytotoxicity of GO and CNFs was studied in the presence of human keratinocyte HaCaT cells. Results: GO or CNFs exhibited no cytotoxicity and high antibacterial activity in direct contact with MRSE and MRSA cells. Furthermore, when GO or CNFs were illuminated with LED light, the MRSE and MRSA cells lost viability. The rate of decrease in colony forming units from 0 to 3 h, measured per mL, increased to 98.5 1.6% and 95.8 1.4% for GO and 99.5 0.6% and 99.7 0.2% for CNFs. Conclusions: This combined antimicrobial approach opens up many biomedical research opportunities and provides an enhanced strategy for the prevention and treatment of Gram-positive multidrug-resistant infections.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Fighting infections due to multidrug-resistant Gram-positive pathogens
    Cornaglia, G.
    CLINICAL MICROBIOLOGY AND INFECTION, 2009, 15 (03) : 209 - 211
  • [2] Tedizolid: A Novel Oxazolidinone with Potent Activity Against Multidrug-Resistant Gram-Positive Pathogens
    George G. Zhanel
    Riley Love
    Heather Adam
    Alyssa Golden
    Sheryl Zelenitsky
    Frank Schweizer
    Bala Gorityala
    Philippe R. S. Lagacé-Wiens
    Ethan Rubinstein
    Andrew Walkty
    Alfred S. Gin
    Matthew Gilmour
    Daryl J. Hoban
    Joseph P. Lynch
    James A. Karlowsky
    Drugs, 2015, 75 : 253 - 270
  • [3] Tedizolid: A Novel Oxazolidinone with Potent Activity Against Multidrug-Resistant Gram-Positive Pathogens
    Zhanel, George G.
    Love, Riley
    Adam, Heather
    Golden, Alyssa
    Zelenitsky, Sheryl
    Schweizer, Frank
    Gorityala, Bala
    Lagace-Wiens, Philippe R. S.
    Rubinstein, Ethan
    Walkty, Andrew
    Gin, Alfred S.
    Gilmour, Matthew
    Hoban, Daryl J.
    Lynch, Joseph P., III
    Karlowsky, James A.
    DRUGS, 2015, 75 (03) : 253 - 270
  • [4] Multidrug-resistant gram-positive pathogens - An update on current microbiological patterns
    Marchese, A
    Debbia, EA
    Bacca, D
    Balistreri, G
    Musolino, B
    Schito, GC
    DRUGS, 1997, 54 (Suppl 6) : 11 - 20
  • [5] Use of linezolid against multidrug-resistant gram-positive infections
    Allan R. Tunkel
    Current Infectious Disease Reports, 2000, 2 (5) : 387 - 388
  • [6] Alkoxyphenyithiazoles with broad-spectrum activity against multidrug-resistant gram-positive bacterial pathogens
    ElAwamy, Moustafa
    Mohammad, Haroon
    Hussien, Abdelrahman
    Abutaleb, Nader S.
    Hagras, Mohamed
    Serya, Rabah A. T.
    Taher, Azza T.
    Abouzid, Khaled A. M.
    Seleem, Mohamed N.
    Mayhoub, Abdelrahman S.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 152 : 318 - 328
  • [7] Antibiotics for multidrug-resistant gram-positive bacteria
    Song, Kyoung-Ho
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2022, 65 (08): : 478 - 489
  • [8] Forthcoming therapeutic perspectives for infections due to multidrug-resistant Gram-positive pathogens
    Cornaglia, G.
    Rossolini, G. M.
    CLINICAL MICROBIOLOGY AND INFECTION, 2009, 15 (03) : 218 - 223
  • [9] Agents for the treatment of multidrug-resistant gram-positive endocarditis
    Long J.K.
    Current Infectious Disease Reports, 2005, 7 (4) : 245 - 250
  • [10] Treatment of pediatric Gram-positive multidrug-resistant infections
    Blumer, Jeffrey
    JOURNAL OF INFECTION, 2009, 59 : S51 - S58